Cambridge Trust’s Organon & Co OGN Stock Holding History

Cambridge Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	$21.7K	Sell	1,155 -30	-3%	-$515	﹤0.01%	511
2023 Q4	$17.1K	Sell	1,185 -10	-0.8%	-$136	﹤0.01%	522
2023 Q3	$20.7K	Sell	1,195 -163	-12%	-$3.4K	﹤0.01%	500
2023 Q2	$28.3K	Sell	1,358 -123	-8%	-$2.67K	﹤0.01%	480
2023 Q1	$34.8K	Buy	1,481 +78	+6%	+$2.09K	﹤0.01%	480
2022 Q4	$39K	Buy	1,403 +466	+50%	+$11.9K	﹤0.01%	477
2022 Q3	$22K	Sell	937 -332	-26%	-$10K	﹤0.01%	561
2022 Q2	$43K	Sell	1,269 -123	-9%	-$4.31K	﹤0.01%	501
2022 Q1	$49K	Sell	1,392 -1,510	-52%	-$51.6K	﹤0.01%	534
2021 Q4	$88K	Buy	+2,902	New	+$94.5K	﹤0.01%	437
2021 Q3	–	Sell	-11,556	Closed	-$349K	–	279
2021 Q2	$349K	Buy	+11,556	New	+$380K	0.01%	208

Other funds holding OGN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

SPC

Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cambridge Trust's OGN Position: Q1 2024 in Review

Cambridge Trust reduced its Organon & Co (OGN) stake by 2.5% in Q1 2024, selling an estimated $515 and leaving 1,155 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #511.

Cambridge Trust first reported a position in OGN in Q2 2021 and has held it in 11 quarters since. The position peaked at $349K in Q2 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

Cambridge Trust held 1,155 shares of Organon & Co worth $21.7K as of Q1 2024.
Cambridge Trust sold 30 Organon & Co shares in Q1 2024, an estimated $515.
Organon & Co made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #511 holding.
Cambridge Trust first reported a position in Organon & Co in Q2 2021 and has held it in 11 quarters since.
Cambridge Trust's Organon & Co position peaked at $349K in Q2 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.